Lupin receives China approval for Oseltamivir Phosphate oral suspension EP News Bureau May 25, 2026 Global pharma major Lupin announced that China’s National Medical Products Administration has approved its Abbreviated New Drug…
Cipla to acquire Inzpera Healthsciences for ₹110.65 Crore EP News Bureau Nov 4, 2025 Cipla Limited has announced that it will acquire a 100% stake in Inzpera Healthsciences for about ₹110.65 crore. Once completed,…
US FDA approves Novartis’ eltrombopag Sanjiv Das Aug 25, 2015 The approval was based on two randomised, double-blinded, placebo-controlled trials enrolling paediatric patients with chronic ITP…
